LeucoTect (Bayer Schering Pharma AG)

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLeucoTect (Bayer Schering Pharma AG)
Drug Alias Nameinflammation/infection imaging
ClassificationDiagnostic agent (In vivo)Small molecules
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsInflammationCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsInflammationCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A